G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Clinical trial NCT01205178 · COMPLETED
Trial details
- NCT number
- NCT01205178
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-02
- Primary completion
- 2013-04-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.